[HTML][HTML] Cataract in diabetes mellitus

H Kiziltoprak, K Tekin, M Inanc… - World journal of …, 2019 - ncbi.nlm.nih.gov
Diabetes mellitus (DM) is a chronic systemic disease that has increases in prevalence over
time. DM can affect all ocular structures, with cataract being the most common ocular …

Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities

J Rehak, M Rehak - Current eye research, 2008 - Taylor & Francis
In branch retinal vein occlusion (BRVO), abnormal arteriovenous crossing with vein
compression, degenerative changes of the vessel wall and abnormal hematological factors …

Cataract surgery in diabetes mellitus: A systematic review

A Kelkar, J Kelkar, H Mehta… - Indian journal of …, 2018 - journals.lww.com
India is considered the diabetes capital of the world, and a significant proportion of patients
undergoing cataract surgery are diabetic. Considering this, we reviewed the principles and …

Therapeutic monoclonal antibodies in ophthalmology

EB Rodrigues, ME Farah, M Maia, FM Penha… - Progress in retinal and …, 2009 - Elsevier
Monoclonal antibodies (mAbs) can be used therapeutically by binding to molecular targets
with high specificity. Therefore, they have excellent therapeutic applications in …

Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy: a pilot study

DS Grewal, R Jain, H Kumar, SPS Grewal - Ophthalmology, 2008 - Elsevier
PURPOSE: To determine whether bevacizumab can reduce bleb failure in patients
undergoing first-time trabeculectomy for primary open-angle glaucoma (POAG) or chronic …

[HTML][HTML] Cataracts in diabetic patients: a review article

MA Javadi, S Zarei-Ghanavati - Journal of ophthalmic & vision …, 2008 - ncbi.nlm.nih.gov
The number of people with diabetes mellitus is increasing and cataracts are one of the most
common causes of visual impairment in these subjects. Advances in cataract surgical …

Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection

JO MASON III, MF White, RM Feist, ML Thomley… - Retina, 2008 - journals.lww.com
Purpose: To report the incidence of acute endophthalmitis as a complication of intravitreal
bevacizumab (Avastin)(IVB) injection in a tertiary vitreoretinal group practice. Methods: A …

Bevacizumab (Avastin) for the treatment of ocular disease

JB Gunther, MM Altaweel - Survey of ophthalmology, 2009 - Elsevier
The use of intravitreal bevacizumab (Avastin) has greatly expanded since its introduction
into ophthalmic care 3 years ago. A PubMed search on 1 August 2008 revealed 51 ocular …

Anti‐vascular endothelial growth factor for neovascular glaucoma

A Simha, K Aziz, A Braganza… - Cochrane Database …, 2020 - cochranelibrary.com
Background Neovascular glaucoma (NVG) is a potentially blinding, secondary glaucoma. It
is caused by the formation of abnormal new blood vessels, which prevent normal drainage …

Anti‐vascular endothelial growth factor for neovascular glaucoma

T Rittiphairoj, G Roberti… - Cochrane Database of …, 2023 - cochranelibrary.com
Background Neovascular glaucoma (NVG) is a potentially blinding, secondary glaucoma. It
is caused by the formation of abnormal new blood vessels, which prevent normal drainage …